Skip to main content
Caplight Logo









Ecovia Bio

Ecovia Bio

Private
Livonia, MichiganFrontier & Industrial Techhttps://ecovia-bio.com/

Last Round

Series B

Feb 3, 2026

Total Funding Raised

$1.6M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Ecovia Bio is a biotechnology company that develops and commercializes sustainable, high-performance biopolymers derived from fermentation processes for the cosmetics, personal care, and agriculture industries.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Sustainable Materials, Advanced Materials, Clean Manufacturing, Fashion & Beauty

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopolymerbiodegradable polymergamma polyglutamic acidγ-PGAgreen chemistrysustainable materialsbio-based ingredientsindustrial fermentationbiotech manufacturingmicroplastic alternativescosmetic ingredientsclean beautyspecialty chemicalsbio-manufacturingsynthetic polymer replacement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ecovia Bio Comparables

Compare Ecovia Bio with similar companies based on industry and business-model similarity.

Ecovia Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nanjing Shineking Biotech Co., Ltd.
86%
Itaconix plc
76%
Lygos
74%

Ecovia Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 3, 2026
SeedOct 3, 2018

Key People

Founding team and executive leadership

Kousay Said

Chief Executive Officer

Executive Team

Ecovia Bio Investors

Notable investors and investment history

Ecovia Bio investors
InvestorRounds
Pointe AngelsSeries B
Accelerate Blue FundSeries B
Pointe AngelsSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 3, 2026

    Led by Pointe Angels with participation from Accelerate Blue Fund.

  • Mar 27, 2025

    Monthly visitors grew 40% MoM.

Ecovia Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ecovia Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ecovia Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersLivonia, Michigan
Employee Range12
Year Founded2014
Last FundingFeb 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?